157 results on '"Ku, Jennifer H."'
Search Results
2. Risk of Corneal Graft Rejection and Vaccination: A Matched Case-Control Study From a United States Integrated Health Care System
3. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis
4. mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
5. Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
6. Antibiotic resistance of urinary tract infection recurrences in a large U.S. integrated health care system
7. Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
8. Natural Language Processing vs Diagnosis Code-Based Methods for Postherpetic Neuralgia Identification: Development and Validation in Real-World Data (Preprint)
9. Validity of Diagnosis Code-Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients
10. Latent Tuberculosis Infection Testing Practices in a Large US Integrated Healthcare System.
11. Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
12. Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis
13. 1156. Real-World Effectiveness of Recombinant Zoster Vaccine in Chinese Adults Aged ≥50 Years in the US
14. 1164. Risk of corneal transplant rejection and vaccination: a case-control study from a large, integrated health care system in Southern California
15. 1874. Prior Screening for Latent Tuberculosis among Patients Diagnosed with Active Tuberculosis: Missed Opportunities?
16. 917. Development and Validation of an Automated Natural Language Processing Method for Identifying Postherpetic Neuralgia from Electronic Health Records
17. 2833. Multi-drug resistance of Escherichia coli from outpatient uncomplicated urinary tract infections in a large U.S. integrated health care organization
18. Prior Screening for Latent Tuberculosis Among Patients Diagnosed With Tuberculosis Disease: Missed Opportunities?
19. Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
20. Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study
21. Multi-drug resistance of Escherichia coli from outpatient uncomplicated urinary tract infections in a large U.S. integrated health care organization
22. Impact of California’s Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data
23. Vaccine Effectiveness of the mRNA-1273 3-dose Primary Series Against COVID-19 in an Immunocompromised Population: A Prospective Observational Cohort Study
24. Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
25. Impact of California’s Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data (Preprint)
26. 1097. Risk of Severe COVID-19 Disease in Individuals with Down syndrome: a Matched Cohort Study from a Large, Integrated Health Care System
27. 784. Real-world effectiveness of the mRNA-12733-dose primary series against COVID-19 in an immunocompromised population Interim results from a prospective observational cohort study
28. Risk of herpes zoster following mRNA COVID-19 vaccine administration
29. Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS-CoV-2 Omicron subvariants: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
30. Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
31. Prediction algorithm to identify tuberculosis in two California health systems
32. Multidrug Resistance of Escherichia coli From Outpatient Uncomplicated Urinary Tract Infections in a Large United States Integrated Healthcare Organization.
33. Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System
34. Evaluation of Mycobacterium avium complex pulmonary disease treatment completion and adherence to ATS/IDSA guidelines
35. Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study
36. Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
37. Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 Patients in the United States
38. Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study
39. Disseminated nontuberculous mycobacteria in HIV-infected patients, Oregon, USA, 2007-2012
40. Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants
41. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
42. Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study
43. Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines.
44. Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults.
45. Determinants of Patient Satisfaction in an Academic Rheumatology Practice
46. Triple antibiotic combination therapy may improve but not resolve granuloma annulare
47. Limited Validity of Diagnosis Code–based Claims to Identify Pseudomonas aeruginosa in Patients with Bronchiectasis in Medicare Data
48. The course of retinal vasculitis
49. ‘Lady Windermere's counterpart? Pulmonary nontuberculous mycobacteria in men with bronchiectasis
50. COVID-19 pandemic management and the rheumatology patient
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.